FOLH1 and prostate cancer: The clinical implications of PSMA PET/CT scan span various domains, including its efficacy in identifying recurrent disease subsequent to prostatectomy or radiation therapy, facilitating precise staging of high-risk prostate cancer, thereby guiding informed treatment strategies, monitoring treatment responses, and discerning disease progression patterns [6].